Dr. Rizwana Afroz is a Postdoctoral Associate at the School of Medicine at Yale University studying endothelial Wnt signaling in the pathophysiology of atherosclerosis. She earned a Doctor of Philosophy (Ph.D.) in Vascular Biology at the University of Queensland in 2021. Her current research focuses on the role of Wnt signaling in the development of atherosclerosis, and searching for alternative vessel wall-directed therapy for the prevention of atherosclerosis.
Dr. Rizwana Afroz is a Postdoctoral Associate at the School of Medicine at Yale University studying endothelial Wnt signaling in the pathophysiology of atherosclerosis. She earned a Doctor of Philosophy (Ph.D.) in Vascular Biology at the University of Queensland in 2021. Her current research focuses on the role of Wnt signaling in the development of atherosclerosis, and searching for alternative vessel wall-directed therapy for the prevention of atherosclerosis.